Could this be the saving grace for the Zip Co Ltd (ASX:Z1P) share price?
Lina Lim | December 18, 2020 12:44pm |
More on:
The
Zip Co Ltd(ASX: Z1P) share price has given back all of its post-QuadPay acquisition gains in recent months and almost halved since its record all-time high of $10.64 back in August.
Its shares jumped as much as 6% on Thursday following a successful $120 million capital raising. However, the discount price and broader weakness in the market is likely to blame for its 3.7% slump today, at the time of writing.
With its plans to accelerate its growth and explore opportunities for international exposure, could this be the saving grace for the Zip share price moving into 2021?
His Highness Sheikh Abdullah bin Zayed Al Nahyan, Minister of Foreign Affairs and International Cooperation, has stressed that the UAE and the Russian Federation share comprehensive strategic ties and are cooperating to create a safe, prosperous and modern region.
Sheikh Abdullah made this statement during a joint news conference in Moscow with the Russian Foreign Minister, Sergey Lavrov.
His Highness said, In the UAE, we are proud to have comprehensive strategic relations with the Russian Federation. During the COVID-19 pandemic, we realised that our relations with Russia will witness significant development in the coming years.
He then expressed his pride in the work of the relevant teams as well as the embassies in Moscow and Abu Dhabi during the COVID-19 crisis, including in the Phase III clinical trials of the Russian vaccine.
The Public Safety LTE & Mobile Broadband Market: 2017 – 2030 – openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.
Sight Diagnostics® Expands to the Gulf Region through a Distribution Partnership with Phoenix Capital
Sight Diagnostics, the company delivering lab-grade Complete Blood Count (CBC) results in minutes, announced a distribution partnership with Phoenix Capital to extend Sight’s footprint in the Middle East. Through the partnership, Sight will provide OLO analyzers – the company’s decentralized, lab-quality diagnostic technology – to medical centers across the Middle East to help providers make quick and informed treatment decisions.
Most outpatient clinics in the United Arab Emirates are currently operating mini-labs with legacy diagnostic technologies like flow cytometry, which require large, expensive machines that aren’t suited for point-of-care (POC) settings. As such, there is an increasing demand for modern POC diagnostics in the Middle East and Africa, with the market projected to reach $2.85 billion by 2024.